Latest filing published 08 May 2024 for NanoString Technologies Inc.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
K. Thomas Bailey: trading record in brief
K. Thomas Bailey (finance chief) discloses dealings in 2 companies, chiefly NanoString Technologies Inc and Angiotech Pharmaceuticals Inc. The record holds 92 filings, for trades running from 17 August 2009 to 6 May 2024.
Both buying and selling appear: 5 purchases worth €339k, against 34 sales worth €5.9M. On balance, insiders were net sellers of €5.6M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 13 share grants and 34 option exercises.
The median purchase comes to €17k.
The latest filing, published on 8 May 2024, reports an option exercise in NanoString Technologies Inc. The most recent open-market purchase was published on 30 May 2023, 1,258 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to K. Thomas Bailey
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 104,545 shares0Common StockSEC:0001401708-24-000091:1
- 69,697 shares0Common StockSEC:0001401708-24-000091:2
- 8,460 shares0Common StockSEC:0001401708-24-000091:0
- 8,460 shares0Common StockSEC:0001401708-24-000029:1
- 34,848 shares0Common StockSEC:0001401708-24-000029:2
- 2,765 shares0Common StockSEC:0001401708-24-000029:0
- 15,000 shares@ US$5.76314.2% of flowCommon StockSEC:0001401708-23-000121:0Canonical exit: 24 Aug 2023 (T+90)
- 2,215 shares@ US$10.160.3% of flowCommon StockSEC:0001401708-23-000070:1
- 1,063 shares@ US$10.160.1% of flowCommon StockSEC:0001401708-23-000070:3
- 3,321 shares@ US$10.160.4% of flowCommon StockSEC:0001401708-23-000070:5
- 2,764 shares0Common StockSEC:0001401708-23-000070:2
- 8,460 shares0Common StockSEC:0001401708-23-000070:4
- 4,989 shares0Common StockSEC:0001401708-23-000070:0
- 1,809 shares@ US$10.390.2% of flowCommon StockSEC:0001401708-23-000020:1
- 4,050 shares0Common StockSEC:0001401708-23-000020:0
- 29,161 shares@ US$8.0539.3% of flowCommon StockSEC:0001401708-22-000157:0Canonical exit: 13 Mar 2023 (T+90)
- 2,110 shares@ US$27.810.7% of flowCommon StockSEC:0001401708-22-000072:1
- 5,377 shares0Common StockSEC:0001401708-22-000072:0
- 5,000 shares@ US$33.8126.9% of flowCommon StockSEC:0001401708-22-000068:0
- 3,058 shares@ US$33.061.1% of flowCommon StockSEC:0001401708-22-000062:2
- 2,764 shares0Common StockSEC:0001401708-22-000062:1
- 4,989 shares0Common StockSEC:0001401708-22-000062:0
- 3,518 shares@ US$31.001.2% of flowCommon StockSEC:0001401708-22-000034:1
- 13,709 shares0Common StockSEC:0001401708-22-000034:0
- 2,003 shares@ US$31.990.7% of flowCommon StockSEC:0001401708-22-000014:1
25 of 92 declarations
